In breast cancer, PGC-1α was shown to stimulate nuclear receptors and transcription factors, including PPARα, estrogen-related receptor alpha (ERRα), NRF1, and NRF2, which in turn led to increased ATP production. This evidence concerns the gene PPARGC1A and breast cancer.